ISCT 2022 - Expansion of Different Types of Therapeutic Cells Using Xenogeneic Free and Gamma Irradiated Human Platelet Lysate.
ISCT 2020 - Development of Standard Protocol for the cGMP Production of Human Mesenchymal Stem/Stromal Cells from Different Source Tissues.
ISCT 2019 - Rapid expansion of Mesenchymal Stem/Stromal Cells using optimized media supplemented with human platelet lysate PLTMax® or PLTGold®, suitable for cGMP expansion at large scale
ISCT 2018 - In vitro expansion of human primary endothelial cells for clinical use using EndoGo™ XF Medium supplemented with PLTGold® human platelet lysate
ISSCR 2017 - Expansion of MSCs for Translational Medicine using MSC NutriStem® Basal Medium and PLTMax® Human Platelet Lysate
ISCT 2021 - Development of a gamma irradiated human platelet lysate for high efficiency cGMP expansion of therapeutic stem cells.
AACR 2019 - Development of Technology for the Large Scale Production of a Novel Dendritic Cell Vaccine for the Treatment of Glioblastoma
ISSCR 2018 - Comparison Of Fetal Bovine Serum And PLTMax® For Long Term Maintenance Of Human Induced Pluripotent Stem Cell Derived Retinal Pigment Epithelial Cells
ISCT 2018 - Impact of media supplementation on the secretion of IFN-γ induced indoleamine 2-3 deoxygenase and resultant immune suppresion by mesenchymal stromal cells
ISCT 2017 - In Vitro Expansion of Mesenchymal Stem Cell Using Media Supplemented with Unfractionated Heparin-Free Platelet Lysate